Literature DB >> 32630723

Rapid Isolation of Rare Isotype-Switched Hybridoma Variants: Application to the Generation of IgG2a and IgG2b MAb to CD63, a Late Endosome and Exosome Marker.

Stéphanie Charrin1, Roberta Palmulli2, Martine Billard3, Denis Clay4, Claude Boucheix3, Guillaume Van Niel5, Eric Rubinstein1.   

Abstract

CD63, a member of the tetraspanin superfamily, is used as a marker of late endosomes and lysosome-related organelles, as well as a marker of exosomes. Here, we selected rare isotype variants of TS63 by sorting hybridoma cells on the basis of their high expression of surface immunoglobulins of the IgG2a and IgG2b subclass. Pure populations of cells secreting IgG2a and IgG2b variants of TS63 (referred to as TS63a and TS63b) were obtained using two rounds of cell sorting and one limited dilution cloning step. We validate that these new TS63 variants are suitable for co-labeling with mAb of the IgG1 subclass directed to other molecules, using anti mouse subclass antibodies, and for the labeling of exosomes through direct binding to protein A-coated gold particles. These mAbs will be useful to study the intracellular localization of various proteins and facilitate electron microscopy analysis of CD63 localization.

Entities:  

Keywords:  CD63; exosomes; isotype switch; late endosomes

Year:  2020        PMID: 32630723     DOI: 10.3390/antib9030029

Source DB:  PubMed          Journal:  Antibodies (Basel)        ISSN: 2073-4468


  2 in total

1.  Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9.

Authors:  Mathilde Mathieu; Nathalie Névo; Mabel Jouve; José Ignacio Valenzuela; Mathieu Maurin; Frederik J Verweij; Roberta Palmulli; Danielle Lankar; Florent Dingli; Damarys Loew; Eric Rubinstein; Gaëlle Boncompain; Franck Perez; Clotilde Théry
Journal:  Nat Commun       Date:  2021-07-19       Impact factor: 14.919

2.  Special Issue "Antibody Engineering for Cancer Immunotherapy".

Authors:  Silvia Crescioli; Ann L White; Sophia N Karagiannis
Journal:  Antibodies (Basel)       Date:  2022-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.